There is a robust set of data that proves the role TNF-α and IL-1β as key inflammatory factors leading to the development of IDD, and identifying molecules that can inhibit the production of these cytokines could be an effective mode of treatment for IDD. This evidence concerns the gene IL1B and intervertebral disk degenerative disorder.